Articles by Disease (Breast Cancer)

Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases

Journal: Current Pharmaceutical Biotechnology
Volume: 5
Page: 369-386
Author(s): G. Grassi, P. Dawson, G. Guarnieri, R. Kandolf and M. Grassi

Therapeutic Antibodies

Journal: Current Molecular Medicine
Volume: 4
Page: 539-547
Author(s): Bernd Groner, Cord Hartmann and Winfried Wels

Phytoestrogen Genistein and Its Pharmacological Interactions with Synthetic Endocrine-Active Compounds

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2749-2757
Author(s): Li You

Pleiotropic Actions of PPARg Activators Thiazolidinediones in Cardiovascular Diseases

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2779-2786
Author(s): Hiroyuki Takano, Hiroshi Hasegawa, Yunzeng Zou and Issei Komuro

COX-2 Selective Inhibitors, Carbonic Anhydrase Inhibition and Anticancer Properties of Sulfonamides Belonging to This Class of Pharmacological Agents

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 4
Page: 625-632
Author(s): Claudiu T. Supuran, Angela Casini, Antonio Mastrolorenzo and Andrea Scozzafava

New Trends in the Development of Transcription Factor Decoy (TFD) Pharmacotherapy

Journal: Current Drug Targets
Volume: 5
Page: 419-430
Author(s): Roberto Gambari

Paucimorphic Alleles versus Polymorphic Alleles and Rare Mutations in Disease Causation: Theory, Observation and Detection

Journal: Current Genomics
Volume: 5
Page: 431-438
Author(s): Ian N.M. Day, Khalid K. Alharbi, Matt Smith, Mohammed A. Aldahmesh, Xiao-He Chen, Andrew J. Lotery, Gabriella Pante-de-Sousa, Guangwei Hou, Shu Ye, Diana Eccles, Nicholas C. P. Cross, Keith R. Fox and Santiago Rodriguez